Decreased salivary flow rate as a dipsogenic factor in hemodialysis patients: Evidence from an observational study and a pilocarpine clinical trial

Journal of the American Society of Nephrology

Volumn 16, Issue 11, 2005, Pages 3418-3429

  Sung, Junne Ming ^a   Kuo, Shih Chen ^b   Guo, How Ran ^c   Chuang, Shu Fen ^a   Lee, Szu Yuan ^d   Huang, Jeng Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d Kuo's General Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; PILOCARPINE; PLACEBO; MUSCARINIC AGENT;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIZZINESS; DRUG MECHANISM; DYSPEPSIA; FEMALE; HEADACHE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SIDE EFFECT; SINGLE BLIND PROCEDURE; SWEATING; THIRST; WEIGHT GAIN; XEROSTOMIA; BODY WEIGHT; DRUG EFFECT; KINETICS; MULTICENTER STUDY; PHYSIOLOGY; PILOT STUDY; RENAL REPLACEMENT THERAPY; SALIVA; SECRETION;

BODY WEIGHT; CROSS-OVER STUDIES; HUMANS; KINETICS; MUSCARINIC AGONISTS; PILOCARPINE; PILOT PROJECTS; RENAL DIALYSIS; SALIVA; SINGLE-BLIND METHOD; THIRST; WEIGHT GAIN; XEROSTOMIA;

EID: 33644874087     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005040346     Document Type: Article

References (50)

1. Baldree KS, Murphy SP, Powers MJ: Stress identification and coping patterns in patients on hemodialysis. Nurs Res 31: 107-112, 1982
2. Abuleo JG: Large interdialytic weight gains: Causes, consequences and corrective measures. Semin Dial 11: 25-32, 1998
3. Kimmel PL, Varela MP, Peterson RA, Weihs KL, Simmens SL, Alleyne S, Amarashinge A, Mishkin GJ, Cruz I, Veis JH: Interdialytic weight gain and survival in hemodialysis patients: Effects of duration of ESRD and diabetes mellitus. Kidney Int 57: 1141-1151, 2000
4. Rahman M, Fu P, Sehgal AR, Smith MC: Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 35: 257-265, 2000
5. Mistiaen P: Thirst, interdialytic weight gain, and thirst-intervention in hemodialysis patients: A literature review. Nephrol Nurs J 28: 601-615, 2001
6. Kooistra MP, Vos J, Koomans HA, Vos PF: Daily home haemodialysis in the Netherlands: Effects on metabolic control haemodynamics and quality of life. Nephrol Dial Transplant 13: 2853-2860, 1998
7. Barre PE, Brunelle G, Gascon-Barre M: A randomized double blind trial of dialysate sodiums of 145 mEq/L, 150 mEq/L and 155 mEq/L. ASAIO Transplant 34: 338-341, 1988
8. Cybulsky AV, Matni A, Hollomby DJ: Effects of high sodium dialysate during maintenance hemodialysis. Nephron 41: 57-61, 1985
9. Daugirdas JT, AI Kudsi RR, Ing TS, Norusis MJ: A double blind evaluation of sodium gradient hemodialysis. Am J Nephrol 5: 163-168, 1985
10. Giovannetti S, Barsotti G, Cupisti A, Morelli E, Agostini B, Posella L, Gazzetti P, Dani L, Aloisi M, Antonelli A, Baldari G, Nerucci B, Caprioli R, Palla R: Dispogenic factors operating in chronic uremia on maintenance hemodialysis. Nephron 66: 413-420, 1994
11. Oldenburg B, MacDonald GJ, Shelley S: Controlled trial of enalapril in patients with chronic fluid overload undergoing dialysis. BMJ 296: 1089-1091, 1998
12. Kuriyama S, Tomonari H, Sakai O: Effects of cilazapril on hyperdipsia in hemodialyzed patients. Blood Purif 14: 35-41, 1996
13. Rogers PW, Kartzman NA: Renal failure, uncontrolled thirst and hyperreninemia. Cessation of thirst with bilateral nephrectomy. JAMA 225: 1236-1238, 1973
14. Molaison EF, Yodrick MK: Stage of change and fluid intake in dialysis patients. Patient Educ Counsel 49: 5-12, 2003
15. Kaplan DA, Czaczkes TW: Personality factors in chronic hemodialysis patients causing non-compliance with the medical regimen. Psychosom Med 34: 333-344, 1972
16. Procci WR: Dietary abuse in maintenance hemodialysis patients. Psychosomatics 19: 16-24, 1978
17. Brunstrom JM: Effect of mouth dryness on drinking behavior and beverage acceptability. Physiol Behav 76: 423-429, 2002
18. Kho HS, Lee SW, Chung SC, Kim YK: Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Ended 88: 316-319, 1999
19. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Chang HR: Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis 36: 1110-1114, 2000
20. Postorino M, Catalano C, Martorano C, Cutrupi S, Marino C, Cozzupoli P, Scudo P, Zoccali C: Salivary and lacrimal secretion is reduced in patients with ESRD. Am J Kidney Dis 42: 722-728, 2003
21. Wu KS, Huang JJ, Kuo SC, Chuang SF, Sung JM: Uremic stomatitis-A forgotten uremic symptom. Dial Transplant 34: 30- 32: 46, 2005
22. Merril A, Peterson LJ: Gingival hemorrhage secondary to uremia. Oral Surg 29: 530-535, 1990
23. Chuang SF, Sung JM, Kuo SC, Huang JJ, Lee SY: Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Ended 99: 689-695, 2005
24. Wirth JB, Folstein MF: Thirst and weight gain during maintenance hemodialysis. Psychosomatics 23: 1125-1134, 1982
25. Bots CP, Brand HS, Veerman ECI, Valentijn-Benz M, Van Amerongen BM, Valentijn RM, Vos PF, Bijlsma JA, Bezemer PD, ter Wee PM, Amerongen AVN: Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int 66: 1662-1668, 2004
26. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, David NG, Muscoplat CC, Gallagher SC: Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329: 390-395, 1993
27. Fox PC, Atkinson JC, Macynski AA, Wolff A, Kung DS, Valdez IJ, Jackson W, Delapenha RA, Shiroky J, Baum BJ: Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 151: 1149-1152, 1991
28. Papas AS, Fernandez MM, Castano RA, Gallagher SC, Trivedi M, Shrotriya RC: Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjögren syndrome. Adv Exp Med Biol 438: 973-978, 1998
29. Nusair S, Rubinow A: The use of oral pilocarpine in xerostomia and Sjögren syndrome. Semin Arthritis Rheum 28: 360-367, 1999
30. Charra B, Laurent G, Chazot C, Calemard E, Terrat JC, Vanel G, Ruffet M: Clinical assessment of dry weight. Nephrol Dial Transplant 11[Suppl 2]: 16-19, 1996
31. Zimmerman RP, Mark RJ, Tran LM, Juillard GF: Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys 37: 571-575, 1997
32. Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL 3rd, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC: Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome. A randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med 159: 174-181, 1999
33. Navazash M: Methods for collecting saliva. Ann N Y Acad Sd 694: 72-77, 1993
34. Mulligan R, Navazash M, Wood GJ: A pilot study comparing three salivary collection methods in an adult population with salivary gland hypofunction. Spec Care Dentist 15: 154-157, 1995
35. Navazesh M, Christensen C, Brightman V: Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 71: 1363-1369, 1992
36. US Renal Data System: USRDS 2004 Annual Data Report, Bethesda, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2005
37. Huang SJ, Yang WC, Chen SC, Dialysis Evaluation Committee of Taiwan Society of Nephrology: Annual report of Dialysis Evaluation Committee 2001. Acta Nephrol Taiwan 14: 139-228, 2002
38. Wang SL, ZT, Lin J, Zhu XZ, Dong H, Zang YG: Investigation of the clinical value of total saliva flow rate. Arch Oral Biol 43: 39-43, 1998
39. Rieke JW, Hafermann MD, Johnson JT, LeVeque FG, Iwamoto R, Steiger BW, Muscoplat C, Gallagher SC: Oral pilocarpine for radiation induced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys 31: 661-669, 1995
40. Sreebny LM, Valdini A: Xerostomia, a neglected symptom. Arch Intern Med 147: 1333-1337, 1987
41. Fregly MJ: Attenuation of pilocarpine-induced drinking by chronic treatment with estrogen. Proc Soc Exp Biol Med 164: 178-183, 1980
42. Thrasher TN, Keil LC, Ramsay DJ: Drinking, oropharyngeal signals and inhibition of vasopressin secretion in dogs. Am J Physiol 253: R509-R518, 1987
43. Figaro MK, Mack GW: Regulation of fluid intake in dehydrated humans: Role of oropharyngeal stimulation. Am J Physiol 273: R1740-R1746, 1997
44. Ferguson DB: Salivary electrolyte. In: Human Saliva: Clinical Chemistry and Microbiology, Vol 1, edited by Tenovuo JO, Boca Raton, CRC Press Inc., 1989, pp 75-99
45. Kinashi M, Ohbayashi S, Ohbayashi M: Detection of amyloid-like fibrils using labial salivary gland biopsy in patients with nondialysis renal insufficiency. Am J Nephrol 9: 435-437, 1989
46. Bots CP, Brand HS, Veerman ECI, Korevaar JC, Valentinjn-Benz M, Bexemer PD, Valentijn RM, Vos PF, Bijlsma JA, ter Wee PM, Van Amerongen BM, Amerongen AVN: Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on hemodialysis. Nephrol Dial Transplant 20: 578-584, 2005
47. Van der Reijden WA, van der Kwaak JS, Vissink A, Veerman EC, Nieuw Amerogen A: Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren syndrome. Arthritis Rheum 39: 57-63, 1996
48. Takahashi S, Morita T, Koda Y, Murayama H, Hirasawa Y: Gastrointestinal involvement of dialysis-related amyloidosis. Clin Nephrol 30: 168-171, 1988
49. Sacs EF, Bloch HM, Milne FJ: Pancreatic supplementation in end-stage renal disease. Nephron 37: 120-122, 1984
50. Avram MM: High prevalence of pancreatic disease in chronic renal failure. Nephron 18: 68-71, 1977